Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 29, 2022
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
[ Fri, Apr 29th 2022
] - WOPRAI
Thu, April 28, 2022
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
Richard Law Initiated (BEAM) at Hold and Held Target at $62 on, Apr 28th, 2022
Richard Law of Credit Suisse, Initiated "Beam Therapeutics Inc." (BEAM) at Hold and Held Target at $62 on, Apr 28th, 2022.
Richard has made no other calls on BEAM in the last 4 months.
There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, 0 agree with Richard's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Richard
- Rick Bienkowski of "SVB Leerink" Maintained at Buy with Increased Target to $121 on, Monday, January 10th, 2022
- Debjit Chattopadhyay of "Guggenheim" Initiated at Strong Buy and Held Target at $130 on, Wednesday, January 5th, 2022
